These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 28703220

  • 1. Tumour-induced osteomalacia.
    Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT.
    Nat Rev Dis Primers; 2017 Jul 13; 3():17044. PubMed ID: 28703220
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumor-induced osteomalacia.
    Florenzano P, Gafni RI, Collins MT.
    Bone Rep; 2017 Dec 13; 7():90-97. PubMed ID: 29021995
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Rare Association Between Osteomalacia, Phosphaturic Mesenchymal Tumor, and Ovarian Cancer: A Case Report and Literature Review.
    Mazza M, Arcidiacono GP, Hoxhaj I, Padoan V, Tasca G, Burei M, Sella S, Simioni P, Giannini S, Mocellin S.
    Calcif Tissue Int; 2024 Aug 13; 115(2):196-203. PubMed ID: 38806758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
    Vollmer S, Olsson K.
    BMJ Case Rep; 2024 May 02; 17(5):. PubMed ID: 38697682
    [Abstract] [Full Text] [Related]

  • 9. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
    Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y.
    Chin J Cancer; 2011 Nov 02; 30(11):794-804. PubMed ID: 22035861
    [Abstract] [Full Text] [Related]

  • 10. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML, Clunie GPR, Houillier P, Jan de Beur SM, Minisola S, Oheim R, Seefried L.
    Bone; 2021 Nov 02; 152():116064. PubMed ID: 34147708
    [Abstract] [Full Text] [Related]

  • 11. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
    Ryhänen EM, Schalin-Jäntti C, Matikainen N.
    Front Endocrinol (Lausanne); 2021 Nov 02; 12():686135. PubMed ID: 34149623
    [Abstract] [Full Text] [Related]

  • 12. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y, Fukumoto S.
    Endocr Rev; 2018 Jun 01; 39(3):274-291. PubMed ID: 29381780
    [Abstract] [Full Text] [Related]

  • 13. Tumor-induced osteomalacia.
    Chong WH, Molinolo AA, Chen CC, Collins MT.
    Endocr Relat Cancer; 2011 Jun 01; 18(3):R53-77. PubMed ID: 21490240
    [Abstract] [Full Text] [Related]

  • 14. Tumor-induced osteomalacia: experience from a South American academic center.
    González G, Baudrand R, Sepúlveda MF, Vucetich N, Guarda FJ, Villanueva P, Contreras O, Villa A, Salech F, Toro L, Michea L, Florenzano P.
    Osteoporos Int; 2017 Jul 01; 28(7):2187-2193. PubMed ID: 28341900
    [Abstract] [Full Text] [Related]

  • 15. [FGF23 tumor induced osteomalacia].
    Gronskaia SA, Belaya ZE, Melnichenko GA.
    Probl Endokrinol (Mosk); 2022 Jul 11; 68(5):56-66. PubMed ID: 36337019
    [Abstract] [Full Text] [Related]

  • 16. Tumor-Induced Osteomalacia.
    Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT.
    Calcif Tissue Int; 2021 Jan 11; 108(1):128-142. PubMed ID: 32504138
    [Abstract] [Full Text] [Related]

  • 17. [Oncogenic osteomalacia and its symptoms: hypophosphatemia, bone pain and pathological fractures].
    Kaniuka-Jakubowska S, Biernat W, Sworczak K.
    Postepy Hig Med Dosw (Online); 2012 Aug 06; 66():554-67. PubMed ID: 22922156
    [Abstract] [Full Text] [Related]

  • 18. Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.
    Kojima D, Ohba S, Abe M, Suzuki A, Horibe S, Tateya I, Hasegawa M, Hirose Y.
    Neuropathology; 2022 Oct 06; 42(5):453-458. PubMed ID: 35880350
    [Abstract] [Full Text] [Related]

  • 19. Tumor induced osteomalacia from a peripheral mesenchymal tumour of the foot.
    Strydom A, Greeff W, Ferrao PNF, Saragas NP.
    Foot (Edinb); 2023 May 06; 55():101979. PubMed ID: 36871520
    [Abstract] [Full Text] [Related]

  • 20. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
    Dutta D, Pandey RK, Gogoi R, Solanki N, Madan R, Mondal A, Dogra S, Thapa P.
    Endokrynol Pol; 2018 May 06; 69(2):205-210. PubMed ID: 29442350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.